SAN FRANCISCO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Stitch Fix, Inc. (NASDAQ:SFIX), the leading online personal styling service, today announced that it will release financial results for its second quarter fiscal year 2025 ended February 1, 2025 after market close on Tuesday, March 11, 2025. Following this, Stitch Fix will hold a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results and outlook. The call will be hosted by Matt Baer, CEO, and David Aufderhaar, CFO. A live webcast of t ...

SUNNYVALE, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, and Scott Blumberg, CFO, will participate in a fireside chat at the upcoming 45th Annual TD Cowen Health Care Conference. The fireside chat will take place on Monday, March 3, 2025, at 6:50 a.m. Pacific Standard Time / 9:50 ...

Core Insights - Tactile Systems Technology, Inc. reported strong financial results for Q4 and full year 2024, highlighting a dynamic year with significant product launches and operational improvements [3][4][9]. Financial Performance - Q4 2024 total revenue increased by $7.9 million, or 10%, reaching $85.6 million compared to $77.7 million in Q4 2023, driven by an 11% increase in lymphedema product sales [4][7]. - Gross profit for Q4 2024 rose by $8.4 million, or 15%, to $64.4 million, with a gross margin of 75.2%, up from 72.1% in Q4 2023 [5][7]. - Operating income for Q4 2024 was $12.5 million, compared to $11.8 million in Q4 2023 [6][8]. - Full year 2024 total revenue increased by $18.6 million, or 7%, to $293.0 million, with a gross margin of 74%, up from 71% in 2023 [9][10]. Net Income and Earnings - Q4 2024 net income was $9.7 million, or $0.40 per diluted share, compared to $8.2 million, or $0.35 per diluted share, in Q4 2023 [8][10]. - Full year 2024 net income was $17.0 million, or $0.70 per diluted share, down from $28.5 million, or $1.23 per diluted share, in 2023 [10]. Cash Flow and Balance Sheet - Operating cash flow for 2024 was $40.7 million, compared to $35.9 million in 2023, with cash at year-end 2024 totaling $94.4 million, up from $61.0 million at the end of 2023 [7][11]. - The company ended 2024 with $26.3 million in outstanding borrowings, down from $29.3 million in 2023 [11]. Strategic Outlook - For 2025, the company expects total revenue to be in the range of $316 million to $322 million, representing growth of approximately 8% to 10% year-over-year [12]. - The company plans to continue investing in enhancing the overall patient experience and expanding treatment options [3].

EVANSTON, Ill., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Fidus Investment Corporation (NASDAQ:FDUS) (“Fidus” or the “Company”) today announced that its Board of Directors on February 18, 2025 declared a base dividend of $0.43 per share and a supplemental dividend of $0.11 per share for the first quarter of 2025. The Company’s dividends will be payable on March 27, 2025 to stockholders of record as of March 20, 2025. When declaring dividends, the Company’s Board of Directors reviews estimates of taxable income avai ...

SAN FRANCISCO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Allbirds, Inc. (NASDAQ: BIRD), a global lifestyle brand that innovates with sustainable materials to make products in a better way, today announced that its fourth quarter and full year 2024 financial results will be released after market close on Tuesday, March 11, 2025. The company will host a conference call to discuss the results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day. A live webcast of the conference call will be available on ...

OKLAHOMA CITY, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Devon Energy Corp. (NYSE: DVN) today reported financial and operational results for the fourth-quarter 2024. The company also declared its quarterly dividend and provided a 2025 outlook. Devon’s earnings release, supplemental financial tables, guidance and related earnings presentation can be accessed via the Investor Relations section of Devon’s website, www.devonenergy.com. The company’s fourth-quarter conference call will be held at 10:00 a.m. Central time ...

WILMINGTON, Del., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report fourth quarter and full year 2024 financial results after market close on Thursday, February 27, 2025. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on February 27, 2025, to discuss Clover Health’s fourth quarter and full year 2024 business and financial results. Fourth Quarter and Full Year 2024 Conference Call and Webcast ...

NextNRG, Inc. is Trading Under the New Ticker Nasdaq: NXXT after Closing of Share Exchange with Ezfill Holdings, Inc.MIAMI, Feb. 18, 2025 (GLOBE NEWSWIRE) -- NextNRG, Inc. (“NextNRG” and the “Company”) (Nasdaq: NXXT), a company focused on renewable energy, mobile fueling, and next-generation energy infrastructure, today announced the closing of a public offering of 5,000,000 shares of common stock at a price to the public of $3.00 per share, for gross proceeds of $15,000,000, before deducting underwriting d ...

Core Insights - Arteris, Inc. reported a record Annual Contract Value (ACV) plus royalties of $65.1 million in Q4 2024, reflecting a 16% year-over-year increase, driven by strong demand in AI-driven enterprise computing and automotive SoCs [2][6] - The company is well-positioned to capitalize on high-growth opportunities in Generative AI and Autonomous Driving, supported by a robust product pipeline and new customer acquisitions [2][5] Financial Highlights - Q4 2024 revenue reached $57.7 million, an 8% increase year-over-year [6] - Non-GAAP gross profit for Q4 2024 was $14.15 million, with a gross margin of 91% [35] - The operating loss for Q4 2024 was $7.1 million, an improvement from a loss of $9.2 million in Q4 2023 [6][35] - Full year 2024 net loss was $33.6 million, or $0.86 per share, compared to a net loss of $36.9 million in 2023 [6][35] Business Highlights - In 2024, Arteris signed 14 new customers, including two major automotive OEMs, and expanded its presence in key technology areas such as chiplets and microcontrollers [6][5] - The company announced design wins with GigaDevice and Menta for automotive microcontrollers and edge AI chiplet designs, respectively [6][5] - Arteris released FlexGen smart NoC IP, which can potentially enhance engineering productivity by up to 10 times while reducing power consumption [6][5] Guidance for 2025 - For Q1 2025, Arteris expects ACV plus royalties to be between $65.5 million and $67.5 million, and revenue to be between $15.7 million and $16.1 million [8] - Full year 2025 guidance includes expected revenue of $66.0 million to $70.0 million and a non-GAAP operating loss of $8.5 million to $12.5 million [8]

REDWOOD CITY, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will attend the TD Cowen 45th Annual Health Care Conference, being held March 3-5, 2025, in Boston, Massachusetts. Management will participate in a fireside chat on Tuesday, March 4, 2025, at 1:10 pm ET. A live webcast of the event will be available in the Investor Relations section of the Company’s ...